A carregar...
Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
B-cell lymphoma 2 (Bcl-2) is a regulator protein involved in apoptosis. In the past few decades, this protein has been demonstrated to have high efficacy in cancer therapy, and several approaches targeting Bcl-2 have been tested clinically (e.g., oblimersen, ABT-737, ABT-263, obatoclax mesylate, and...
Na minha lista:
| Publicado no: | Biomed Res Int |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6791192/ https://ncbi.nlm.nih.gov/pubmed/31662966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1212369 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|